Evidence map›Paper›PMID 33809709›Full record

ArticlePathogens (Basel, Switzerland)2021

Characterisation of a G2P[4] Rotavirus Outbreak in Western Australia, Predominantly Impacting Aboriginal Children.

Celeste M Donato, Nevada Pingault, Elena Demosthenous, Susie Roczo-Farkas, Julie E Bines

Abstract read
In one paragraph

Article in Pathogens (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Lab-scale production of postbiotic proteins fromFrontiers in microbiology · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Rotaviruses and Rotavirus Vaccines.Pathogens (Basel, Switzerland) · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Celeste M DonatoEnteric Diseases Group, Murdoch Children's Research Institute, Parkville 3052, Australia.ORCID 0000-0001-9262-6550
Nevada PingaultDepartment of Health Western Australia, Communicable Disease Control Directorate, Perth 6004, Australia.
Elena DemosthenousEnteric Diseases Group, Murdoch Children's Research Institute, Parkville 3052, Australia.
Susie Roczo-FarkasEnteric Diseases Group, Murdoch Children's Research Institute, Parkville 3052, Australia.ORCID 0000-0002-0650-6198
Julie E BinesEnteric Diseases Group, Murdoch Children's Research Institute, Parkville 3052, Australia.ORCID 0000-0002-5452-6601

Funding

Commonwealth Serum Laboratories NADepartment of Health, Australian Government NAGlaxoSmithKline Australia ID116120National Health and Medical Research Council 1113269National Health and Medical Research Council 1163346
6 · The paper itself

Abstract

In May, 2017, an outbreak of rotavirus gastroenteritis was reported that predominantly impacted Aboriginal children ≤4 years of age in the Kimberley region of Western Australia. G2P[4] was identified as the dominant genotype circulating during this period and polyacrylamide gel electrophoresis revealed the majority of samples exhibited a conserved electropherotype. Full genome sequencing was performed on representative samples that exhibited the archetypal DS-1-like genome constellation: G2-P[4]-I2-R2-C2-M2-A2-N2-T2-E2-H2 and phylogenetic analysis revealed all genes of the outbreak samples were closely related to contemporary Japanese G2P[4] samples. The outbreak samples consistently fell within conserved sub-clades comprised of Hungarian and Australian G2P[4] samples from 2010. The 2017 outbreak variant was not closely related to G2P[4] variants associated with prior outbreaks in Aboriginal communities in the Northern Territory. When compared to the G2 component of the RotaTeq vaccine, the outbreak variant exhibited mutations in known antigenic regions; however, these mutations are frequently observed in contemporary G2P[4] strains. Despite the level of vaccine coverage achieved in Australia, outbreaks continue to occur in vaccinated populations, which pose challenges to regional areas and remote communities. Continued surveillance and characterisation of emerging variants are imperative to ensure the ongoing success of the rotavirus vaccination program in Australia.

Indexed as

AboriginalG2P[4]gastroenteritisIndigenousoutbreakrotavirusvaccineWestern Australiawhole genome sequencing

Identifiers

PMID33809709
PMCPMC8002226

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.